Medicine and Dentistry
Macrophage
90%
Duchenne Muscular Dystrophy
81%
Monocyte
45%
Diaphragm
36%
Combination Therapy
27%
Pathogenesis
18%
Muscle Strength
18%
Muscle
18%
Pathology
18%
Fibrosis
9%
Immune Response
9%
Phenotype
9%
Mediator
9%
Necrosis
9%
Ligand
9%
Mesenchymal Stem Cell
9%
Chemokine
9%
Diaphragm Muscle
9%
Muscular Dystrophy
9%
Muscle Regeneration
9%
Polarization
9%
Weakness
9%
Macrophage Polarization
9%
Immunology and Microbiology
CCR2
100%
Monocyte
45%
Mouse
36%
Animal
18%
Muscle
18%
Bone Marrow
18%
Polarization
18%
Muscle Strength
18%
Immune Response
9%
Mediator
9%
Phenotype
9%
Chemokine
9%
Mouse Model
9%
CCL2
9%
Mesenchymal Stem Cell
9%
Muscle Regeneration
9%
Biochemistry, Genetics and Molecular Biology
CCR2
100%
Monocyte
45%
Mouse
36%
Genetic Ablation
18%
Animal
18%
Muscle Strength
18%
Polarization
18%
Phenotype
9%
Mediator
9%
Immune Response
9%
Muscle Regeneration
9%
Chemokine
9%
CCL2
9%
Genetics
9%
Neuroscience
CCR2
100%
Muscular Dystrophy
90%
Monocyte
45%
Ligand
9%
Necrosis
9%
Phenotype
9%
CCL2
9%
Chemokine
9%
Mesenchymal Stem Cell
9%
Pharmacology, Toxicology and Pharmaceutical Science
Duchenne Muscular Dystrophy
81%
Mouse
36%
Pathogenesis
18%
Animal
18%
Ligand
9%
Mouse Model
9%
Necrosis
9%
Fibrosis
9%
Weakness
9%
Muscular Dystrophy
9%